Resumo
Chronic Chagas disease affects 10 million people, one-third of which will develop life-threatening cardiac disease years after infection. One of the most challenging tasks for the control and treatment of chronic Chagas disease is the development of anti-Trypanosoma cruzi therapy effective at this phase, the one where most cases are diagnosed. Benznidazole, which together with Nifurtimox …